The world is experiencing widespread ongoing transmission of respiratory illness caused by the novel new Coronavirus (COVID-19).

We know very well that, evolving consumer expectations, complex health and technology ecosystems, force health care stakeholders to invest in value-based care, innovative devices in compliance with stringent regulations.